Inhibition of tumor angiogenesis by a single-chain antibody directed against vascular endothelial growth factor

Cancer Research

Volumn 60, Issue 16, 2000, Pages 4311-4314

  Vitaliti, Alessandra ^a   Wittmer, Mariana ^a   Steiner, Rudolf ^a   Wyder, Lorenza ^a   Neri, Dario ^b   Klemenz, Roman ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY V65; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CHICK EMBRYO; CHORIOALLANTOIS; CONTROLLED STUDY; GENE THERAPY; MOUSE; NONHUMAN; NUDE MOUSE; PHAGE DISPLAY; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

3T3 CELLS; ALLANTOIS; ANGIOGENESIS INHIBITORS; ANIMALS; ANTIBODY SPECIFICITY; CELL LINE, TRANSFORMED; CHICK EMBRYO; CHORION; ENDOTHELIAL GROWTH FACTORS; HUMANS; IMMUNOGLOBULIN FRAGMENTS; LYMPHOKINES; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PEPTIDE LIBRARY; RATS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034662636     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Seminars in medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis
2. The vascular endothelial growth factor family of polypeptides
3. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family
4. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor
5. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity
6. Characterization of the increase in vascular permeability induced by vascular permeability factor in vivo
7. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
8. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders
9. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
10. Pharmacokinetics and biodistribution of genetically-engineered antibodies
11. Versican is expressed in the proliferating zone in the epidermis and in association with the elastic network of the dermis
12. Antibody fragments from a "single pot" phage display library as immunochemical reagents
13. By-passing immunization. Human antibodies from V-gene libraries displayed on phage
14. 32P]ATP
15. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity (addendum)
16. Partial reversion of the transformed phenotype in HRAS-transfected tumorigenic cells by transfer of a human gene
17. Increased binding affinity and valence of recombinant antibody fragments lead to improved targeting of tumoral angiogenesis
18. Microautoradiographic analysis of the normal organ distribution of radioiodinated single-chain Fv and other immunoglobulin forms
19. In vivo tumor targeting of a recombinant single-chain antigen-binding protein
20. Minibody. A novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts